Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease.

Saved in:
Bibliographic Details
Title: Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease.
Authors: Kar S; International Neuroscience Institute, Rudolf-Pichlmayr-Strasse 4, Hannover 30625, Germany., Perrelli A; Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.; CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.; Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA., Bali KK; Department of Experimental Pain Research, Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim 68167, Germany., Mastrocola R; Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.; CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy., Kar A; Department of Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Hannover 30625, Germany.; Ricarda-Huch-Street-10B, Hannover 30880, Germany., Khan B; Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover 30625, Germany., Gand L; Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover 30625, Germany., Nayak A; Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover 30625, Germany., Hartmann C; Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover 30625, Germany., Kunz WS; Institute of Experimental Epileptology and Cognition Research and Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, Bonn 53127, Germany., Samii A; International Neuroscience Institute, Rudolf-Pichlmayr-Strasse 4, Hannover 30625, Germany., Bertalanffy H; International Neuroscience Institute, Rudolf-Pichlmayr-Strasse 4, Hannover 30625, Germany., Retta SF; Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.; CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.
Source: Genes & diseases [Genes Dis] 2023 Apr 03; Vol. 11 (1), pp. 67-71. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V. on behalf of KeAi Communications Co. Ltd Country of Publication: Netherlands NLM ID: 101635967 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3042 (Electronic) Linking ISSN: 23523042 NLM ISO Abbreviation: Genes Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3042
DOI:10.1016/j.gendis.2023.02.045